Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response-Guided Therapy Stopping Rule for Pegasys in Korean CHB
NCT02822547Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Mar 2015
- Primary completion
- Sep 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Yonsei University. Status: unknown.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02822547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02822547.